-
Product Insights
Candidiasis – Drugs In Development, 2023
Global Markets Direct’s, ‘Candidiasis - Drugs In Development, 2023’, provides an overview of the Candidiasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Candidiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Aspergillosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Aspergillosis - Drugs In Development, 2023’, provides an overview of the Aspergillosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Aspergillosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Mycoses – Drugs In Development, 2023
Global Markets Direct’s, ‘Mycoses - Drugs In Development, 2023’, provides an overview of the Mycoses pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mycoses, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Cutaneous Mycosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Cutaneous Mycosis - Drugs In Development, 2023’, provides an overview of the Cutaneous Mycosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cutaneous Mycosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Onychomycosis (Tinea Unguium) – Drugs In Development, 2023
Global Markets Direct’s, ‘Onychomycosis (Tinea Unguium) - Drugs In Development, 2023’, provides an overview of the Onychomycosis (Tinea Unguium) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Onychomycosis (Tinea Unguium), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Vulvovaginal Candidiasis – Drugs In Development, 2023
Global Markets Direct’s, ‘Vulvovaginal Candidiasis - Drugs In Development, 2023’, provides an overview of the Vulvovaginal Candidiasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Vulvovaginal Candidiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Dermatomycoses – Drugs In Development, 2023
Global Markets Direct’s, ‘Dermatomycoses - Drugs In Development, 2023’, provides an overview of the Dermatomycoses pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dermatomycoses, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Allergic Bronchopulmonary Aspergillosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Allergic Bronchopulmonary Aspergillosis - Drugs In Development, 2023’, provides an overview of the Allergic Bronchopulmonary Aspergillosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Allergic Bronchopulmonary Aspergillosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Cryptococcosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Cryptococcosis - Drugs In Development, 2023’, provides an overview of the Cryptococcosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cryptococcosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Dermatophytosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Dermatophytosis - Drugs In Development, 2023’, provides an overview of the Dermatophytosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dermatophytosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.